ABL Bio Inc (298380) — Capital Reinvestment Ratio
ABL Bio Inc (298380) has a Capital Reinvestment Ratio of 0.22x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩38.30 Billion) in capital expenditures (₩8.47 Billion). See ABL Bio Inc balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ABL Bio Inc Capital Reinvestment Ratio (2022–2022)
This chart tracks ABL Bio Inc's Capital Reinvestment Ratio across 1 annual periods. Check how aggressively does ABL Bio Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for ABL Bio Inc (2022–2022)
Year-by-year Capital Reinvestment Ratio for ABL Bio Inc from 2022 to 2022. For live market cap and broader valuation context, see market value of ABL Bio Inc.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.03x | ₩72.13 Billion | ₩2.06 Billion | — |